Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · technology

AI-Powered Biology: Building the Next Generation of Genomics & Therapeutics

3 August 2026 · By · Wire by Fusion42

Published

3 August 2026

Topic

technology

◆ Sectors

AI InfrastructureBiotechDrug Discovery

◆ Source

Read at nebius.com →

◆ Verified

Fusion42 · 3 August 2026 · Fusion42 review

NVIDIA and Nebius are hosting a workshop on the BioNeMo Agent Toolkit, a platform that helps life sciences teams build AI-powered workflows to accelerate genomics research, drug discovery, and computational biology.

This Wire brief sits within Fusion42's coverage of AI Infrastructure, Biotech and Drug Discovery.

◆ ◆ The Wire takeaway

You can now build AI workflows tailored for biotech using NVIDIA's agent platform, opening a new route to cut research time and cost in genomics and drug discovery.

◆ Coverage

1 source · 3 Aug 2026

◆ Related on Wire

◆ Topics

AI InfrastructureBiotechDrug Discoveryaibiotechdrug-discoverygenomicslife-sciences